Nickel carcinogenesis

Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis

Volumn 533, Issue 1-2, 2003, Pages 67-97

  Kasprzak, Kazimierz S ^a   Sunderman Jr , F William ^b   Salnikow, Konstantin ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

Author keywords

Epigenetic toxicity; Genotoxicity; Histones; Hypoxia; Nickel carcinogenesis; Oxidative damage

Indexed keywords

CALCIUM; IRON; MAGNESIUM; MANGANESE; NICKEL; ZINC;

CARCINOGENESIS; DNA DAMAGE; ELECTROPLATING INDUSTRY; GENETIC ANALYSIS; GENOTOXICITY; HUMAN; HYPOXIA; LUNG FIBROSIS; NONHUMAN; POLLUTION; PRIORITY JOURNAL; RESPIRATORY TRACT CANCER; REVIEW; SKIN ALLERGY; WELDING;

EID: 0344845185     PISSN: 00275107     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mrfmmm.2003.08.021     Document Type: Review

References (317)

1. International Agency for Research on Cancer, IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, vol. 49, Chromium, Nickel and Welding, IARC Scientific Publications, Lyon, 1990, pp. 257-445.
2. F.W. Sunderman Jr., Nickel, in: M. Anke, M. Ihnat, M. Stoeppler (Eds.), Elements and their Compounds in the Environment, Wiley/VCH, Weinheim, in press.
3. Barceloux D.G. Nickel. Clin. Tox. 37:1999;239-258.
4. Coogan T.P., Latta D.M., Snow E.T., Costa M. Toxicity and carcinogenicity of nickel compounds. Crit. Rev. Toxicol. 19:1989;341-384.
5. Denkhaus E., Salnikow K. Nickel essentiality, toxicity, and carcinogenicity. Crit. Rev. Oncol. Hematol. 42:2002;35-56.
6. R.P. Hausinger, Biochemistry of Nickel, Plenum Press, New York, 1993.
7. E. Nieboer, J.O. Nriagu (Eds.), Nickel and Human Health, Wiley, New York, 1992.
8. Ragsdale S.W. Nickel biochemistry. Curr. Opin. Chem. Biol. 2:1998;208-215.
9. Savolainen H. Biochemical and clinical aspects of nickel toxicity. Rev. Environ. Health. 11:1996;167-173.
10. F.W. Sunderman Jr., Nickel, in: H.G. Seiler, H. Sigel, A. Sigel (Eds.), Handbook on Toxicity of Inorganic Compounds, Marcel Dekker, New York, 1988, pp. 453-468.
11. F.W. Sunderman Jr., Nickel, in: J.B. Sullivan Jr., G.R. Krieger (Eds.), Clinical Environmental Health and Toxic Exposures, Williams and Wilkins, Baltimore, 2001, pp. 905-910.
12. Sunderman F.W. Jr., Aitio A., Morgan L.M., Norseth T. Biological monitoring of nickel. Toxicol. Ind. Health. 2:1986;17-78.
13. Hopfer S.M., Linden J.V., Crisostomo M.C., Catalanatto F.A., Galen M., Sunderman F.W. Jr. Hypernickelemia in hemodialysis patients. Trace Elem. Med. 2:1985;68-72.
14. Fell G.S., Maharaj D. Trace metal contamination of albumin solutions used for plasma exchange. Lancet. 2:1986;467-468.
15. Leach C.N. Jr., Sunderman F.W. Jr. Nickel contamination of human serum albumin solutions. N. Engl. J. Med. 313:1985;1232.
16. Leach C.N. Jr., Sunderman F.W. Jr. Hypernickelemia following coronary arteriography, caused by nickel in the radiographic contrast medium. Ann. Clin. Lab. Sci. 17:1987;137-144.
17. Gordon P.M., White M.I., Scotland T.R. Generalized sensitivity from an implanted orthopaedic antibiotic minichain containing nickel. Contact Dermat. 30:1994;181-182.
18. J.J. Hostynek, H.I. Maibach, Nickel and the Skin, CRC Press, Boca Raton, 2002, pp. 1-249.
19. T. Norseth, M. Piscator, Nickel, in: L. Friberg, G.F. Nordberg, V.B. Vouk (Eds.), Handbook on the Toxicology of Metals, Elsevier/North-Holland Biomedical Press, Amsterdam, 1979, pp. 541-553.
20. P. Grandjean, Human exposure to nickel, in: F.W. Sunderman Jr., (Ed.), Nickel in the Human Environment, vol. 53, IARC Scientific Publications, Lyon,1984, pp. 469-485.
21. Baader E.W. Berufkrebs. Neu. Ergeb. Geb. Krebskrankh. 1:1937;104-128.
22. National Academy of Sciences (NAS) Nickel, Medical and Biologic Effects of Environmental Pollutants, NAS Press, Washington, DC, 1975, pp. 1-277.
23. Doll R. Report of the International Committee on Nickel Carcinogenesis in Man. Scand. J. Work. Environ. Health. 16:1990;9-82.
24. Grimsrud T.K., Berge S.R., Martinsen J.I., Andersen A. Lung cancer incidence among Norwegian nickel-refinery workers, 1953-2000. J. Environ. Monit. 5:2003;190-197.
25. K.S. Kasprzak, Animal studies, an overview, in: E. Nieboer, J.O. Nriagu (Eds.), Nickel and Human Health: Current Perspectives, Wiley, New York, 1992, pp. 387-420.
26. Oller A.R., Costa M., Oberdörster G. Carcinogenicity assessment of selected nickel compounds. Toxicol. Appl. Pharmacol. 143:1997;152-166.
27. Sunderman F.W. Jr. The current status of nickel carcinogenesis. Ann. Clin. Lab. Sci. 3:1973;157-180.
28. F.W. Sunderman Jr., Carcinogenicity of nickel compounds in animals, in: F.W. Sunderman Jr., (Ed.), Nickel in the Human Environment, vol. 53, IARC Scientific Publications, Lyon, 1984, pp. 127-142.
29. Sunderman F.W. Jr., Morgan L.G., Andersen A., Ashley D., Forouhar F.A. Histopathology of sinonasal and lung cancers in nickel refinery workers. Ann. Clin. Lab. Sci. 19:1989;44-50.
30. Hughes K., Meek M.E., Newhook R., Chan P.K.L. Speciation and health risk assessment of metals: evaluation of effects associated with forms present in the environment. Regul. Toxicol. Pharmacol. 22:1995;213-220.
31. Sunderman F.W. Jr. Carcinogenicity of metal alloys in orthopedic prostheses: clinical and experimental studies. Fundam. Appl. Toxicol. 13:1989;205-216.
32. J.K. Avery, A. Goldberg, K.S. Kasprzak, L.C. Lucas, H.D. Millard, J.R. Natiella, R. Rhyne, N.W. Rupp, D.F. Williams, Local tissue reaction and carcinogenesis (Section Report), in: B.R. Lang, H.F. Morris, M.E. Razzoog, (Eds.), Biocompatibility, Toxicity, and Hypersensitivity to Alloy Systems Used in Dentistry, University of Michigan, Ann Arbor, 1986, pp. 262-270.
33. McGregor D.B., Baan R.A., Partensky C., Rice J.M., Wilbourn J.D. Evaluation of the carcinogenic risks to humans associated with surgical implants and other foreign bodies - a report of an IARC Monographs Programme Meeting. Eur. J. Cancer. 36:2000;307-313.
34. Campbell J.A. Lung tumours in mice and man. Br. Med. J. 1:1943;179-183.
35. Poirier L.A., Theiss J.C., Arnold L.J., Shimkin M.B. Inhibition by magnesium and calcium acetates of lead subacetate- and nickel acetate-induced lung tumors in strain A mice. Cancer Res. 44:1984;1520-1522.
36. Kasprzak K.S., Diwan B.A., Konishi N., Misra M., Rice J.M. Initiation by nickel acetate and promotion by sodium barbital of renal cortical epithelial tumors in male F344 rats. Carcinogenesis. 11:1990;647-652.
37. F. Pott, M. Rippe, M. Roller, M. Csicsaky, M. Rosenbruch, Carcinogenicity of nickel compounds and nickel alloys in rats by intraperitoneal injection, in: E. Nieboer, J.O. Nriagu (Eds.), Nickel and Human Health: Current Perspectives, Wiley, New York, 1992, pp. 491-502.
38. Diwan B.A., Kasprzak K.S., Rice J.M. Transplacental carcinogenic effects of nickel(II) acetate in the renal cortex. Carcinogenesis. 13:1992;1351-1357.
39. Gilman J.P.W. Metal carcinogenesis. II. A study on the carcinogenic activity of cobalt, copper, iron, and nickel compounds. Cancer Res. 22:1962;158-165.
40. Hildebrand H.F., Biserte G. Cylindrical laminated bodies in nickel-subsulphide-induced rhabdomyosarcoma in rabbits. Eur. J. Cell. Biol. 19:1979;276-280.
41. Sunderman F.W. Jr., Maenza R.M., Alpass P.R., Mitchell J.M., Damjanov I., Goldblatt P.J. Carcinogenicity of nickel subsulfide in Fischer rats and Syrian hamsters after administration by various routes. Adv. Exp. Med. Biol. 91:1977;57-67.
42. Yamashiro S., Gilman J.P., Hulland T.J., Abandowitz H.M. Nickel sulphide-induced rhabdomyosarcomata in rats. Acta Pathol. Jpn. 30:1980;9-22.
43. Kasprzak K.S., Gabryel P., Jarczewska K. Carcinogenicity of nickel(II)hydroxides and nickel(II)sulfate in Wistar rats and its relation to the in vitro dissolution rates. Carcinogenesis. 4:1983;275-279.
44. 2). J. Pathol. 157:1989;263-274.
45. 63Ni(II) in rats and rabbits Res. Commun. Chem. Pathol. Pharmacol. 6:1973;663-676.
46. Oskarsson A., Andersson Y., Tjalve H. Fate of nickel subsulfide during carcinogenesis studied by autoradiography and X-ray powder diffraction. Cancer Res. 39:1979;4175-4182.
47. Sano N., Shibata M., Izumi K., Otsuka H. Histopathological and immunohistochemical studies on nickel sulfide-induced tumors in F344 rats. Jpn. J. Cancer Res. 79:1988;212-221.
48. Stoner G.D., Shimkin M.B., Troxell M.C., Thompson T.L., Terry L.S. Test for carcinogenicity of metallic compounds by the pulmonary tumor response in strain A mice. Cancer Res. 36:1976;1744-1747.
49. Saknyn A.V., Blokhin V.A. Development of malignant tumors in rats under the influence of nickel-containing aerosols. Vopr. Onkol. 24:1978;44-48.
50. 2 Res. Commun. Chem. Pathol. Pharmacol. 7:1974;755-762.
51. Jasmin G., Riopelle J.L. Renal carcinomas and erythrocytosis in rats following intrarenal injection of nickel subsulfide. Lab. Invest. 35:1976;71-78.
52. Jasmin G., Solymoss B. The topical effects of nickel subsulfide on renal parenchyma. Adv. Exp. Med. Biol. 91:1977;69-83.
53. Sunderman F.W. Jr., Maenza R.M., Hopfer S.M., Mitchell J.M., Allpass P.R., Damjanov I. Induction of renal cancers in rats by intrarenal injection of nickel subsulfide. J. Environ. Pathol. Toxicol. 2:1979;1511-1527.
54. Kasprzak K.S., Diwan B.A., Rice J.M. Iron accelerates while magnesium inhibits nickel-induced carcinogenesis in the rat kidney. Toxicology. 90:1994;129-140.
55. 2. Proc. Soc. Expl. Biol. Med. 148:1975;774-776.
56. 2. Exp. Hematol. 6:1978;43-47.
57. Sunderman F.W. Jr., McCully K.S., Hopfer S.M. Association between erythrocytosis and renal cancers in rats following intrarenal injection of nickel compounds. Carcinogenesis. 5:1984;1511-1517.
58. Damjanov I., Sunderman F.W., Mitchell J.M., Allpass P.R. Induction of testicular sarcoma in Fischer rats by intratesticular injection of nickel subsulfide. Cancer Res. 38:1978;268-276.
59. Albert D.M., Gonder J.R., Papale J., Craft J.L., Dohlman H.G., Reid M.C., Sunderman F.W. Jr. Induction of ocular neoplasms in Fischer rats by intraocular injection of nickel subsulfide. Invest. Ophthalmol. Vis. Sci. 22:1982;768-782.
60. Okamoto M. Induction of ocular tumor by nickel subsulfide in the Japanese common newt, Cynops pyrrhogaster. Cancer Res. 47:1987;5213-5217.
61. Sunderman F.W. Jr., Donnelly A., West B., Kincaid J.F. Nickel poisoning. IX. Carcinogenesis in rats exposed to nickel carbonyl. Arch. Ind. Health. 20:1959;36-41.
62. Ottolenghi A.D., Haseman J.K., Payne W.W., Falk H.L., MacFarland H.N. Inhalation studies of nickel sulfide in pulmonary carcinogenesis of rats. J. Natl. Cancer Inst. 54:1975;1165-1172.
63. Yarita T., Nettesheim P. Carcinogenicity of nickel subsulfide for respiratory tract mucosa. Cancer Res. 38:1978;3140-3145.
64. Dunnick J.K., Elwell M.R., Radovsky A.E., Benson J.M., Hahn F.F., Nikula K.J., Barr E.B., Hobbs C.H. Comparative carcinogenic effects of nickel subsulfide, nickel oxide, or nickel sulfate hexahydrate chronic exposures in the lung. Cancer Res. 55:1955;5251-5256.
65. NTP Study, Toxicology and Carcinogenesis Studies of Nickel Oxide 1996 (CAS No. 10101-97-0 CAS No. 1313-99-1 CAS No. 12035-72-2) in F344/N Rats and B6C3F1 Mice (Inhalation Studies), US DHHS, Atlanta, GA.
66. Maenza R.M., Pradhan A.M., Sunderman F.W. Jr. Rapid induction of sarcomas in rats by combination of nickel sulfide and 3,4-benzpyrene. Cancer Res. 31:1971;2067-2071.
67. Kasprzak K.S., Marchow L., Breborowicz J. Pathological reactions in rat lungs following intratracheal injection of nickel subsulfide and 3,4-benzpyrene. Res. Commun. Chem. Pathol. Pharmacol. 6:1973;237-245.
68. Sunderman F.W. Jr., Kasprzak K.S., Lau T.J., Minghetti P.O., Maenza R.M., Becker N., Onkelinx C., Goldblatt P.J. Effect of manganese on carcinogenicity and metabolism of nickel subsulfide. Cancer Res. 36:1976;1790-1800.
69. Sunderman F.W. Jr., McCully K.S. Effects of manganese compounds on carcinogenicity of nickel subsulfide in rats. Carcinogenesis. 4:1983;461-465.
70. Kasprzak K.S., Quander R.V., Poirier L.A. Effects of calcium and magnesium salts on nickel subsulfide carcinogenicity in Fischer rats. Carcinogenesis. 6:1985;1161-1166.
71. Kasprzak K.S., Ward J.M., Poirier L.A., Reichardt D.A., Denn A.C. III, Reynolds C.W. Nickel-magnesium interactions in carcinogenesis: dose-effects and involvement of natural killer cells. Carcinogenesis. 8:1987;1005-1011.
72. Kasprzak K.S., Kovatch R.M., Poirier L.A. Inhibitory effect of zinc on nickel subsulfide carcinogenesis in Fischer rats. Toxicology. 52:1988;253-262.
73. Kasprzak K.S., Diwan B.A., Rice J.M. Iron accelerates while magnesium inhibits nickel-induced carcinogenesis in the rat kidney. Toxicology. 90:1994;129-140.
74. K.S. Kasprzak, R.E. Rodriguez, Inhibitory effects of zinc, magnesium, and iron on nickel subsulfide carcinogenesis in rat skeletal muscle, in: E. Nieboer, J.O. Nriagu (Eds.), Nickel in Human Health: Current Perspectives, Wiley, New York, 1992, pp. 545-559.
75. Sunderman F.W. Jr. Organ and species specificity in nickel subsulfide carcinogenesis. Basic Life Sci. 24:1983;107-127.
76. Rodriguez R.E., Misra M., Diwan B.A., Riggs C.W., Kasprzak K.S. Relative susceptibilities of C57BL/6, (. C57BL/6×C3H/He )F1, and C3H/He mice to acute toxicity and carcinogenicity of nickel subsulfide Toxicology. 107:1996;131-140.
77. Daniel M.R. Strain differences in the response of rats to the injection of nickel sulphide. Br. J. Cancer. 20:1966;886-895.
78. Rodriguez R.E., Misra M., North S.L., Kasprzak K.S. Nickel-induced lipid peroxidation in the liver of different strains of mice and its relation to nickel effects on antioxidant systems. Toxicol. Lett. 57:1991;269-281.
79. Fisher G.L., Chrisp C.E., McNeill D.A. Lifetime effects of intratracheally instilled nickel subsulfide on B6C3F1 mice. Environ. Res. 40:1986;313-320.
80. Sunderman F.W. Jr. Recent research on nickel carcinogenesis. Environ. Health Perspect. 40:1981;131-141.
81. Eitinger T., Mandrand-Berthelot M.A. Nickel transport systems in microorganisms. Arch. Microbiol. 173:2000;1-9.
82. Pikalek P., Necasek J. The mutagenic activity of nickel in Corynebacterium sp. Folia Microbiol. (Praha). 28:1983;17-21.
83. DiPaolo J.A., Casto B.C. Quantitative studies of in vitro morphological transformation of Syrian hamster cells by inorganic metal salts. Cancer Res. 39:1979;1008-1013.
84. Biedermann K.A., Landolph J.T. Induction of anchorage independence in human diploid foreskin fibroblasts by carcinogenic metal salts. Cancer Res. 47:1987;3815-3823.
85. Patierno S.R., Dirscherl L.A., Xu J. Transformation of rat tracheal epithelial cells to immortal growth variants by particulate and soluble nickel compounds. Mutat. Res. 300:1993;179-193.
86. M. Costa, Mechanisms of nickel genotoxicity and carcinogenicity, in: L.W. Chang (Ed.), Toxicology of Metals, CRC Press, Boca Raton, 1996, pp. 245-251.
87. Kerckaert G.A., LeBoeuf R.A., Isfort R.J. Use of the Syrian hamster embryo cell transformation assay for determining the carcinogenic potential of heavy metal compounds. Fundam. Appl. Toxicol. 34:1996;67-72.
88. Costa M., Nye J.S., Sunderman F.W. Jr., Allpass P.R., Gondos B. Induction of sarcomas in nude mice by implantation of Syrian hamster fetal cells exposed in vitro to nickel subsulfide. Cancer Res. 39:1979;3591-3597.
89. Trott D.A., Cuthbert A.P., Overell R.W., Russo I., Newbold R.F. Mechanisms involved in the immortalization of mammalian cells by ionizing radiation and chemical carcinogens. Carcinogenesis. 16:1995;193-204.
90. Hansen K., Stern R.M. In vitro toxicity and transformation potency of nickel compounds. Environ. Health Perspect. 51:1983;223-226.
91. Saxholm H.J., Reith A., Brogger A. Oncogenic transformation and cell lysis in C3H/10T 1/2 cells and increased sister chromatid exchange in human lymphocytes by nickel subsulfide. Cancer Res. 41:1981;4136-4139.
92. Tveito G., Hansteen I-L., Dalen H., Haugen A. Immortalization of normal human kidney epithelial cells by nickel(II). Cancer Res. 49:1989;1829-1835.
93. Haugen A., Ryberg D., Hansteen I-L., Dalen H. Transformation of human kidney epithelial cells to tumorigenicity by nickel(II) and. v -Ha-ras oncogene Biol. Trace Element Res. 21:1989;451-458.
94. Rivedal E., Sanner T. Metal salts as promoters of in vitro morphological transformation of hamster embryo cells initiated by benzo[a]pyrene. Cancer Res. 41:1981;2950-2953.
95. Miki H., Kasprzak K.S., Kenney S., Heine U.I. Inhibition of intercellular communication by nickel(II): antagonistic effect of magnesium. Carcinogenesis. 8:1987;1757-1760.
96. Foulkes E.C., McMullen D.M. On the mechanism of nickel absorption in the rat jejunum. Toxicology. 38:1986;35-42.
97. Refvik T., Andreassen T. Surface binding and uptake of nickel(II) in human epithelial kidney cells: modulation by ionomycin. Carcinogenesis. 16:1995;1107-1112.
98. Zaroogian G., Yevich P., Anderson S. Effect of selected inhibitors on cadmium, nickel, and benzo[a]pyrene uptake into brown cells of Mercenaria mercenaria. Marine Environ. Res. 35:1993;41-45.
99. 2+ impairs thrombin-induced signal transduction by acting on the agonist and/or receptor in human platelets. Am. J. Physiol. 265:1993;C1681- C1688.
100. Tallkvist J., Wing A.M., Tjalve H. Enhanced intestinal nickel absorption in iron-deficient rats. Pharmacol. Toxicol. 75:1994;244-249.
101. Schafer S.G., Forth W. The influence of tin, nickel, and cadmium on the intestinal absorption of iron. Ecotoxicol. Environ. Safety. 7:1983;87-95.
102. 59Fe during absorption in iron-deficient and iron-adequate jejunal rat segments ex vivo Toxicology. 185:2003;141-153.
103. Gunshin H., Mackenzie B., Berger U.V., Gunshin Y., Romero M.R., Boron W.F., Nussberger S., Gollan J.L., Hediger M.A. Cloning and characterization of a mammalian proton-coupled metal-ion transporter. Nature. 388:1997;482-488.
104. Tallkvist J., Tjalve H. Transport of nickel across monolayers of human intestinal Caco-2 cells. Toxicol. Appl. Pharmacol. 151:1998;117-122.
105. Knopfel M., Schulthess G., Funk F., Hauser H. Characterization of an integral protein of the brush border membrane mediating the transport of divalent metal ions. Biophys. J. 79:2000;874-884.
106. Ghio A.J., Richards J.H., Dittrich K.L., Samet J.M. Metal storage and transport proteins increase after exposure of the rat lung to an air pollution particles. Toxicol. Pathol. 26:1998;388-394.
107. Costa M., Simmons-Hansen J., Bedrossian C.W.M., Bonura J., Caprioli R.M. Phagocytosis, cellular distribution, and carcinogenic activity of particulate nickel compounds in tissue culture. Cancer Res. 41:1981;2868-2876.
108. Heck J.D., Costa M. Surface reduction of amorphous NiS particles potentiates their phagocytosis and subsequent induction of morphological transformation in Syrian hamster embryo cells. Cancer Lett. 15:1982;19-26.
109. Kuehn K., Fraser C.B., Sunderman F.W. Jr. Phagocytosis of particulate nickel compounds by rat peritoneal macrophages in vitro. Carcinogenesis. 3:1982;321-326.
110. Costa M., Abbracchio M.P., Simmons-Hansen J. Factors influencing the phagocytosis, neoplastic transformation, and cytotoxicity of particulate nickel compounds in tissue culture systems. Toxicol. Appl. Pharmacol. 60:1981;313-323.
111. Costa M., Mollenhauer H.H. Carcinogenic activity of particulate nickel compounds is proportional to their cellular uptake. Science. 209:1980;515-517.
112. Evans R.M., Davies P.J., Costa M. Video time-lapse microscopy of phagocytosis and intracellular fate of crystalline nickel sulfide particles in cultured mammalian cells. Cancer Res. 42:1982;2729-2735.
113. Fletcher G.G., Rosetto F.E., Turnbull J.D., Nieboer E. Toxicity, uptake, and mutagenicity of particulate and soluble nickel compounds. Environ. Health Perspect. 102(Suppl. 3):1994;69-79.
114. Kasprzak K.S., Sunderman F.W. Jr. Mechanisms of dissolution of nickel subsulfide in rats serum. Res. Commun. Chem. Pathol. Pharmacol. 16:1977;95-108.
115. Kuehn K., Sunderman F.W. Jr. Dissolution half-times of nickel compounds in water, rat serum, and renal cytosol. J. Inorg. Biochem. 17:1982;29-39.
116. A. Longstaff, A.I.T. Walker, R. Jackh, Nickel oxide, potential carcinogenicity - a review and further evidence, in: F.W. Sunderman (Ed.), Nickel in the Human Environment, vol. 53, IARC Scientific Publications, Lyon, 1984, pp. 235-244.
117. Sen P., Conway K., Costa M. Comparison of the localization of chromosome damage induced by calcium chromate and nickel compounds. Cancer Res. 47:1987;2142-2147.
118. Conway K., Costa M. Nonrandom chromosomal alterations in nickel-transformed Chinese hamster embryo cells. Cancer Res. 49:1989;6032-6038.
119. Sen P., Costa M. Incidence and localization of sister chromatid exchanges induced by nickel and chromium compounds. Cancer Res. 7:1985;1527-1533.
120. Sahu R.K., Katsifis S.P., Kinney P.L., Christie N.T. Effects of nickel sulfate, lead sulfate, and sodium arsenite alone and with UV light on sister chromatid exchanges in cultured human lymphocytes. J. Mol. Toxicol. 2:1989;129-136.
121. 2. Mutagenesis. 5:1990;583-589.
122. 2 in magnesium-insoluble regions of fractionated Chinese hamster ovary cell chromatin. Cancer Res. 45:1985;5787-5794.
123. Kasprzak K.S. The role of oxidative damage in metal carcinogenicity. Chem. Res. Toxicol. 4:1991;604-615.
124. S. Zienolddiny, D. Ryberg, A. Haugen, Induction of microsatellite mutations by oxidative agents in human lung cancer cell lines, Carcinogenesis (2000) 1521-1526.
125. Chiocca S.M., Sterner D.A., Biggart N.W., Murphy E.C. Jr. Nickel mutagenesis: alteration of the MuSVts110 thermosensitive splicing phenotype by a nickel-induced duplication of the 3′ splice site. Mol. Carcinog. 4:1991;61-71.
126. Rosetto F.E., Turnbull J.D., Nieboer E. Characterization of nickel-induced mutations. Sci. Total Environ. 148:1994;201-206.
127. Higinbotham K.G., Rice J.M., Diwan B.A., Kasprzak K.S., Reed C.D., Perantoni A.O. GGT to GTT transversions in codon 12 of the K-ras oncogene in rat renal sarcomas induced with nickel subsulfide or nickel subsulfide/iron are consistent with oxidative damage to DNA. Cancer Res. 52:1992;4747-4751.
128. Harty L.C., Guinee D.G. Jr., Travis W.D., Bennett W.P., Jett J., Coby T.V., Tazelaar H., Trastek V., Pairolero P., Liotta L.A., Harris C.C., Caporaso N.E. p53 mutations and occupational exposures in a surgical series of lung cancers. Cancer Epidemiol. Biomark. Prev. 5:1996;997-1003.
129. Biggart N.W., Costa M. Assessment of the uptake and mutagenicity of nickel chloride in Salmonella tester strains. Mutat. Res. 175:1986;209-215.
130. Kargacin B., Klein C.B., Costa M. Mutagenic responses of nickel oxides and nickel sulfides in Chinese hamster V79 cell lines as the xanthine-guanine phosphoribosyl transferase locus. Mutat. Res. 300:1993;63-72.
131. Lee Y-W., Klein C.B., Kargacin B., Salnikow K., Kitahara J., Dowjat K., Zhitkovich A., Christie N.T., Costa M. Carcinogenic nickel silences gene expression by chromatin condensation and DNA methylation: a new model for epigenetic carcinogens. Mol. Cell. Biol. 15:1995;2547-2557.
132. Rodriguez-Arnaiz R., Ramos P. Mutagenicity of nickel sulpate in Drosophila melanogaster. Mutat. Res. 170:1986;115-117.
133. Dubins J.S., LaVelle J.M. Nickel(II) genotoxicity: potentiation of mutagenesis of simple alkylating agents. Mutat. Res. 162:1986;187-199.
134. Mayer C., Klein R.G., Wesch H., Schmezer P. Nickel subsulfide is genotoxic in vitro but shows no mutagenic potential in respiratory tract tissues of Big Blue rats and Muta Mouse mice in vivo after inhalation. Mutat Res. 420:1998;85-98.
135. N.T. Christie, D.M. Tummolo, C.B. Klein, T.G. Rossman, Role of Ni(II) in mutation, in: E. Nieboer, J.O. Nriagu (Eds.), Nickel and Human Health: Current Perspectives, Wiley, New York, 1992, pp. 305-317.
136. Biggart N.W., Gallick G.E., Murphy E.C. Jr. Nickel-induced heritable alterations in retroviral transforming gene expression. J. Virol. 61:1987;2378-2388.
137. Broday L., Peng W., Kuo M.H., Salnikow K., Zoroddu M., Costa M. Nickel compounds are novel inhibitors of histone H4 acetylation. Cancer Res. 60:2000;238-241.
138. Sunderman F.W. Jr., Hopfer S.M., C Reid M., K Shen S., Kevorkian C.B. Erythropoietin-mediated erythrocytosis in rodents after intrarenal injection of nickel subsulfide. Yale J. Biol. Med. 55:1982;123-136.
139. Sunderman F.W. Jr., McCully K.S., Hopfer S.M. Association between erythrocytosis and renal cancers in rats following intrarenal injection of nickel compounds. Carcinogenesis. 5:1984;1511-1517.
140. Semenza G.L., Wang G.L. A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation. Mol. Cell. Biol. 12:1992;5447-5454.
141. Graven K.K., McDonald R.J., Farber H.W. Hypoxia regulation of endothelial glyceraldehyde-3-phosphate dehydrogenase. Am. J. Physiol. 43:1998;347-355.
142. Salnikow K., Blagosklonny M.W., Ryan H., Johnson R., Costa M. Carcinogenic nickel induces genes involved in hypoxic stress. Cancer Res. 60:2000;38-41.
143. Namiki A., Brogi E., Kearney M., Kim E.A., Wu T., Couffinhal T., Varticovski L., Isner J.M. Hypoxia induces vascular endothelial growth factor in cultured human endothelial cells. J. Biol. Chem. 270:1995;31189-31195.
144. 2+ compounds. Cancer Res. 58:1998;2182-2189.
145. Salnikow K., An W.G., Melillo G., Blagosklonny M.V., Costa M. Nickel-induced transformation shifts the balance between HIF-1α and p53 transcription factors. Carcinogenesis. 20:1999;1819-1823.
146. Semenza G.L. Expression of hypoxia-inducible factor 1: mechanisms and consequences. Biochem. Pharmacol. 59:2000;47-53.
147. 2, and the 3 PHDs: how animal cells signal hypoxia to the nucleus. Cell. 107:2001;1-3.
148. Carmeliet P., Dor Y., Herbert J.M., Fukumura D., Brusselmans K., Dewerchin M., Neeman M., Bono F., Abramovitch R., Maxwell P., Koch C.J., Ratcliffe P., Moons L., Jain R.K., Collen D., Keshet E. Role of HIF-1α in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis. Nature. 394:1998;485-490.
149. Folkman J. Tumor angiogenesis: therapeutic implications. N. Engl. J. Med. 285:1971;1182-1186.
150. Semenza G.L., Roth P.H., Fang H.-M., Wang G.L. Transcriptional regulation of genes encoding glycolitic enzymes by hypoxia-inducible factor 1. J. Biol. Chem. 269:1994;23757-23763.
151. Rolfs A., Kvietikova I., Gassmann M., Wenger R.H. Oxygen-regulated transferrin expression is mediated by hypoxia-inducible factor-1. J. Biol. Chem. 272:1997;20055-20062.
152. Melillo G., Musso T., Sica A., Taylor L.S., Cox G.W., Varesio L. A hypoxia-responsive element mediates a novel pathway of activation of the inducible nitric oxide synthase promoter. J. Exp. Med. 182:1995;1683-1693.
153. Garayoa M., Martinez A., Lee S., Pio R., An W.G., Neckers L., Trepel J., Montuenga L.M., Ryan H., Johnson R., Gassmann M., Cuttitta F. Hypoxia-inducible factor-1 (HIF-1) up-regulates adrenomedullin expression in human tumor cell lines during oxygen deprivation: a possible promotion mechanism of carcinogenesis. Mol. Endocrinol. 14:2000;848-862.
154. Salnikow K., Davidson T., Costa M. The role of hypoxia-inducible signaling pathway in nickel carcinogenesis. Environ. Health Perspect. 110(Suppl. 5):2002;831-834.
155. Salnikow K., Davidson T., Kluz T., Chen H., Zhou D., Costa M. GeneChip analysis of signaling pathways effected by nickel. J. Environ. Monitor. 5:2003;1-5.
156. Salnikow K., Davidson T., Zhang Q., Chen L.C., Su W., Costa M. The involvement of hypoxia-inducible transcription factor-1-dependent pathway in nickel carcinogenesis. Cancer Res. 63:2003;3524-3530.
157. Salnikow K., Su W., Blagosklonny M.V., Costa M. Carcinogenic metals induce hypoxia-inducible factor-stimulated transcription by reactive oxygen species-independent mechanism. Cancer Res. 60:2000;3375-3378.
158. Sutter C.H., Laughner E., Semenza G.L. Hypoxia-inducible factor 1α protein expression is controlled by oxygen-regulated ubiqitination that is disrupted by deletions and missense mutations. Proc. Natl. Acad. Sci. U.S.A. 97:2000;4748-4753.
159. Jewell U.R., Kvietikova I., Scheid A., Bauer C., Wenger R.H., Gassmann M. Induction of HIF-1alpha in response to hypoxia is instantaneous. FASEB J. 15:2001;1312-1314.
160. 2 sensing. Science. 292:2001;464-468.
161. 2-regulated prolyl hydroxylation. Science. 292:2001;468-472.
162. Yu F., White S.B., Zhao Q., Lee F.S. HIF-1α binding to VHL is regulated by stimulus-sensitive proline hydroxylation. Proc. Natl. Acad. Sci. U.S.A. 98:2001;9630-9635.
163. Ohh M., Park C.W., Ivan M., Hoffman M.A., Kim T.-Y., Huang L.E., Pavletich N., Chau V., Kaelin W.G. Ubiquination of hypoxia-inducible factor requires direct binding to the beta-domain of the von Hippel-Lindau protein. Nat. Cell Biol. 2:2000;423-427.
164. McNeill L.A., Hewitson K.S., Claridge T.D., Seibel J.F., Horsfall L.E., Schofield C.J. Hypoxia-inducible factor asparaginyl hydroxylase (FIH-1) catalyses hydroxylation at the beta-carbon of asparagine-803. Biochem J. 367:2002;571-575.
165. Lando D., Peet D.J., Whelan D.A., Gorman J.J., Whitelaw M.L. Asparagine hydroxylation of the HIF transactivation domain a hypoxic switch. Science. 295:2002;858-861.
166. Salnikow K., Cosentino S., Klein C., Costa M. Loss of thrombospondin transcriptional activity in nickel-transformed cells. Mol. Cell. Biol. 14:1994;851-858.
167. Salnikow K., Wang S., Costa M. Induction of activating transcription factor I by nickel and its role as a negative regulator of thrombospondin I gene expression. Cancer Res. 57:1997;5060-5066.
168. Shaywitz A.J., Greenberg M.E. CREB: a stimulus-induced transcription factor activated by a diverse array of extracellular signals. Annu. Rev. Biochem. 68:1999;821-861.
169. Goebeler M., Meinardus-Hager G., Roth J., Goerdt S., Sorg C. Nickel chloride and cobalt chloride, two common contact sensitizers, directly induce expression of intercellular adhesion molecule-1 (ICAM-1), vascular cell adhesion molecule-1 (VCAM-1), and endothelial leukocyte adhesion molecule (ELAM-1) by endothelial cells. J. Invest. Dermatol. 100:1993;759-765.
170. Goebeler M., Roth J., Brocker E.B., Sorg C., Schulze-Osthoff K. Activation of nuclear factor-kappa B and gene expression in human endothelial cells by the common haptens nickel and cobalt. J. Immunol. 155:1995;2459-2467.
171. Hernandez-Boussard T., Rodriguez-Tome P., Montesano R., Hainaut P. IARC p53 mutation database: a relational database to compile and analyze p53 mutations in human tumors and cell lines. Hum. Mutat. 14:1999;1-8.
172. Maehle L., Metcalf R.A., Ryberg D., Bennett W.P., Harris C.C., Haugen A. Altered p53 gene structure and expression in human epithelial cells after exposure to nickel. Cancer Res. 52:1992;218-221.
173. Weghorst C.M., Dragnev K.H., Buzard G.S., Thorne K.L., Vandeborne G.F., Vincent K.A., Rice J.M. Low incidence of point mutations detected in the p53 tumor suppressor gene from chemically induced rat renal mesenchymal tumors. Cancer Res. 154:1994;215-219.
174. Shiao Y-H., Lee S-H., Kasprzak K.S. Cell cycle arrest, apoptosis and p53 expression in nickel (II) acetate-treated Chinese hamster ovary cells. Carcinogenesis. 19:1998;1203-1207.
175. An W.G., Kanekal M., Simon M.C., Maltepe E., Blagosklonny M.V., Neckers L.M. Stabilization of wild-type p53 by hypoxia-inducible factor 1alpha. Nature. 392:1998;405-408.
176. Lee W.H., Bookstein R., Lee E.Y. Studies on the human retinoblastoma susceptibility gene. J. Cell. Biochem. 38:1988;213-227.
177. Kouzarides T. Transcriptional control by the retinoblastoma protein. Semin. Cancer Biol. 6:1995;91-98.
178. Lin X., Dowjat W.K., Costa M. Nickel-induced transformation of human cells causes loss of the phosphorylation of the retinoblastoma protein. Cancer Res. 54:1994;2751-2754.
179. Rani A.S., Qu D., Sidhu M.K., Panagakos F., Shah V., Klein K.M., Brown N., Pathak S., Kumar S. Transformation of immortal, non-tumorigenic osteoblast-like human osteosarcoma cells to the tumorigenic phenotype by nickel sulfate. Carcinogenesis. 14:1993;947-953.
180. Lin X., Costa M. Transformation of human osteoblasts to anchorage-independent growth by insoluble nickel particles. Environ. Health Perspect. 102(Suppl. 3):1994;289-292.
181. Miller A.C., Blakely W.F., Livengood D., Whittaker T., Xu J., Ejnik J.W., Hamilton M.M., Parlette E., John T.S., Gerstenberg H.M., Hsu H. Transformation of human osteoblast cells to the tumorigenic phenotype by depleted uranium-uranyl chloride. Environ. Health Perspect. 106:1998;465-471.
182. Trapasso F., Krakowiak A., Cesari R., Arkles J., Yendamuri S., Ishii H., Vecchione A., Kuroki T., Bieganowski P., Pace H.C., Huebner K., Croce C.M., Brenner C. Designed FHIT alleles establish that Fhit-induced apoptosis in cancer cells is limited by substrate binding. Proc. Natl. Acad. Sci. U.S.A. 100:2003;1592-1597.
183. Kowara R., Karaczyn A., Fivash M.J., Kasprzak K.S. In vitro inhibition of the enzymatic activity of tumor suppressor FHIT gene product by carcinogenic transition metals. Chem. Res. Toxicol. 15:2002;319-325.
184. R. Kowara, K. Salnikow, B.A. Diwan, R.M. Bare, M.P. Waalkes, K.S. Kasprzak, Reduced Fhit protein expression in nickel-transformed mouse cells and in nickel-induced murine sarcomas, Mol. Cell. Biochem., in press.
185. Lee S.H., Shiao Y.-H., Plisov S., Kasprzak K.S. Nickel(II) acetate-treated Chinese hamster ovary cells differentially express vimentin, hSNF2H homologue, and H ferritin. Biochem. Biophys. Res. Commun. 258:1999;592-595.
186. Lumb G., Sunderman F.W. Sr. The mechanism of malignant tumor induction by nickel subsulfide. Ann. Clin. Lab. Sci. 18:1988;353-366.
187. Burns L.G., Peterson C.L. Protein complexes for remodeling chromatin. Biochem. Biophys. Acta. 1350:1997;159-168.
188. Cheng R.Y.S., Zhao A., Alvord W.G., Powell D., Bare R.M., Masuda A., Takahashi T., Anderson L.M., Kasprzak K.S. Gene expression dose-response changes in microarrays after exposure of human peripheral lung epithelial cells to nickel(II). Toxicol. Appl. Pharmacol. 191:2003;22-39.
189. McDowell S.A., Gammon K., Bachurski C.J., Wiesdt J.S., Leikauf J.E., Prows D.R., Leikauf G.D. Differential gene expression in the initiation and progression of nickel-induced acute lung injury. Am. J. Respir. Cell Mol. Biol. 23:2000;466-474.
190. Sirover M.A., Loeb L.A. Infidelity of DNA synthesis in vitro: screening for potential metal mutagens and carcinogens. Science. 194:1976;1434-1436.
191. Hartwig A., Mullenders L.H.F., Schlepegrell R., Kasten U., Beyersmann D. Nickel(II) interferes with the incision step in nucleotide excision repair in mammalian cells. Cancer. 54:1994;4045-4051.
192. Hartwig A. Carcinogenicity of metal compounds: possible role of DNA repair inhibition. Toxicol. Lett. 28:1998;102-103.
193. 6-methylguanine in mammalian cells. Arch. Toxicol. 72:1998;681-689.
194. Schwerdtle T., Seidel A., Hartwig A. Effect of soluble and particulate nickel compounds on the formation and repair of stable benzo[a]pyrene DNA adducts in human lung cells. Carcinogenesis. 23:2002;47-53.
195. Hartwig A., Asmuss M., Blessing H., Hoffmann S., Jahnke G., Khandelwal S., Pelzer A., Burkle A. Interference by toxic metal ions with zinc-dependent proteins involved in maintaining genomic sttability. Food Chem. Toxicol. 40:2002;1179-1184.
196. Bal W., Schwerdtle T., Hartwig A. Mechanism of nickel assault on the zinc finger of DNA repair protein XPA. Chem. Res. Toxicol. 16:2003;242-248.
197. Hartwig A., Asmuss M., Ehleben I., Herzer U., Kostelac D., Pelzer A., Schwerdtle T., Burkle A. Interference by toxic metal ions with DNA repair processes and cell cycle control: molecular mechanisms. Environ. Health Perspect. 110(Suppl. 5):2002;797-799.
198. Kasprzak K.S., Bialkowski K. Inhibition of antimutagenic enzymes, 8-oxo-dGTPases. J. Inorg. Biochem. 79:2000;231-236.
199. Pozzan T., Rizzuto R., Volpe P., Meldolesi J. Molecular and cellular physiology of intracellular calcium stores. Physiol. Rev. 74:1994;595-636.
200. Rosen L.B., Ginty D.D., Greenberg M.E. Calcium regulation of gene expression. Adv. Second Messenger Phosphoprotein Res. 30:1995;225-253.
201. Nicotera P., Orrenius S. The role of calcium in apoptosis. Cell Calcium. 23:1988;173-180.
202. K.S. Kasprzak, M.P. Waalkes, The role of calcium, magnesium, and zinc in carcinogenesis, in: L.A. Poirier, P.M. Newberne, M.W. Pariza, (Eds.), Essential Nutrients in Carcinogenesis, Plenum Press, New York, 1986, pp. 497-515.
203. Swierenga S.H.H., Whitfield J.F., Gillan D.J. Alteration by malignant transformation of the calcium requirements for cell proliferation in vitro. J. Natl. Cancer Inst. 57:1976;125-129.
204. Swierenga S.H.H., Whitfield J.F., Boynton A.L. Age-related and carcinogen-induced alterations of the extracellular growth factor requirements for cell proliferation in vitro. J. Cell. Physiol. 94:1978;171-180.
205. 2+ in the regulation of nickel-inducible Cap43 gene expression. Toxicol. Appl. Pharmacol. 160:1999;127-132.
206. Funakoshi T., Inoue T., Shimada H., Kojima S. The mechanism of nickel uptake by rat primary hepatocyte cultures: role of calcium channels. Toxicology. 124:1997;21-26.
207. Zamponi G.W., Bourinet E., Snutch T.P. Nickel block of a family of neuronal calcium channels: subtype- and subunit-dependent action at multiple sites. J. Membrane Biol. 151:1996;77-90.
208. Smith J.B., Dwyer S.D., Smith L. Cadmium evokes inositol polyphosphate formation and calcium mobilization. Evidence for a cell surface receptor that cadmium stimulates and zinc antagonizes. J. Biol. Chem. 264:1989;7115-7118.
209. 2+ concentration. Eur. J. Biochem. 250:1997;689-697.
210. Glennon J.D., Sarkar B. Nickel(II) transport in human blood serum: studies of nickel(II)-binding human albumin and to native-sequence peptide, and ternary complex formation with L-histidine. Biochem. J. 203:1982;15-23.
211. Templeton D.M., Sarkar B. Peptide and carbohydrate complexes in human kidney. Biochem. J. 230:1985;35-42.
212. Predki P.F., Harford C., Brar P., Sarkar B. Further characterization of the N-terminal copper(II)- and nickel(II)-binding motif of proteins. Studies of metal binding to chicken serum albumin and the native sequence peptide. Biochem. J. 287:1992;211-215.
213. Donaldson L.W., Skrynnikov N.R., Choy W.Y., Muhandiram D.R., Sarkar B., Forman-Kay J.D., Kay L.E. Structural characterization of proteins with an attached ATCUN motif by paramagnetic relaxation enhancement NMR spectroscopy. J. Am. Chem. Soc. 123:2001;9843-9847.
214. J. Crowe, H. Dobeli, R. Gentz, E. Hochuli, D. Stuber, K. Henco, 6xHis-Ni-NTA chromatography as a superior technique in recombinant protein expression/purification, in: A.J. Harwood (Ed.), Methods in Molecular Biology, Humana Press, Totowa, NJ, 1994, pp. 371-387.
215. Bauman J.W., Liu J., Klaassen C.D. Production of metallothionein and heat-shock proteins in response to metals. Fundam. Appl. Toxicol. 21:1993;15-22.
216. 2 Clin. Chem. 18:1972;1478-1484.
217. 63Ni (II) to ultrafiltrable constituents of rabbit serum in vivo and in vitro Clin. Chem. 21:1975;521-527.
218. 63Ni (II) by serum albumin Res. Commun. Chem. Pathol. Pharmacol. 5:1973;459-474.
219. 1H NMR spectroscopy Biochemistry. 23:1984;2832-2838.
220. Bal W., Christodoulou J., Sadler P.J., Tucker A. Multi-metal binding site of serum albumin. J. Inorg. Biochem. 70:1998;33-39.
221. 2 Eisei Kagaku. 35:1989;19-29.
222. 2-macroglobulin from rabbit serum. Biochemistry. 10:1971;1647-1651.
223. Nomoto S., Sunderman F.W. Jr. Presence of nickel in alpha-2 macroglobulin isolated from human serum by high performance liquid chromatography. Ann. Clin. Lab. Sci. 18:1988;78-84.
224. 2-macroglobulin in vivo and in vitro Bioinorg. Chem. 3:1974;87-94.
225. Abdulwajid A.W., Sarkar B. Nickel-sequestering renal glycoprotein. Proc. Natl. Acad. Sci. U.S.A. 80:1983;4509-4512.
226. 63Ni (II) into lung and liver subcellular fractions of Balb/C mice Carcinogenesis. 4:1983;387-392.
227. 4 Acta Pharmacol. Toxicol. 45:1979;306-314.
228. 2 Ann. Clin. Lab. Sci. 11:1981;488-496.
229. 2 treated rats Res. Commun. Chem. Pathol. Pharmacol. 39:1983;477-492.
230. Templeton D.M., Sarkar B. Nickel binding to the C-terminal tryptic fragment of a peptide from human kidney. Biochem. Biophys. Acta. 884:1986;382-386.
231. Harford C., Sarkar B. Neuromedin C binds Cu(II) and Ni(II) via the ACTUN motif: implications for the CNS and cancer growth. Biochem. Biophys. Res. Commun. 209:1995;877-882.
232. E. Nieboer, A.R. Stafford, S.L. Evans, J. Dolovich, in: F.W. Sunderman Jr., (Ed.), Nickel in the Human Environment, Oxford University Press, Oxford, 1984, pp. 321-331.
233. 2+. Biochem. Biophys. Res. Commun. 216:1995;209-215.
234. Ozaki T., Nakamura Y., Enomoto H., Hirose M., Sakiyama S. Overexpression of DAN gene product in normal rat fibroblasts causes a retardation of the entry into the S phase. Cancer Res. 55:1995;895-900.
235. Sunderman F.W. Jr., Varghese A.H., Kroftova O.S., Grbac-Ivankovic S., Kotyza J., Datta A.K., Davis M., Bal W., Kasprzak K.S. Characterization of pNiXa, a serpin of Xenopus laevis oocytes and embryos, and its histidine-rich, Ni(II)-binding domain. Mol. Reprod. Dev. 44:1996;507-524.
236. Kotyza J., Varghese A.H., Korza G., Sunderman F.W. Jr. Interaction of serine proteinases with pNiXa, a serpin from Xenopus oocytes and embryos. Biochim. Biophys. Acta. 1382:1998;266-276.
237. (2+)-binding protein (pNiXc) on western blots of Xenopus laevis oocytes and embryos is the monomer of fructose-1,6-bisphosphate aldolase A Biochim. Biophys. Acta. 1247:1995;81-89.
238. Grbac-Ivankovic S., Antonijczuk K., Varghese A.H., Plowman M.C., Antonijczuk A., Korza G., Ozols J., Sunderman F.W. Jr. Lipovitellin 2 beta is the 31 kD Ni(2+)-binding protein (pNiXb) in Xenopus oocytes and embryos. Mol. Reprod. Dev. 38:1994;256-263.
239. Gorlich D., Prehn S., Laskey R.A., Hartmann E. Isolation of a protein that is essential for the first step of nuclear protein import. Cell. 79:1994;767-778.
240. Pace H.C., Garrison P.N., Robinson A.K., Barnes L.D., Draganescu A., Rosler A., Blackburn G.M., Siprashvili Z., Croce C.M., Huebner K., Brenner C. Genetic, biochemical, and crystallographic characterization of Fhit-substrate complexes as the active signaling form of Fhit. Proc. Natl. Acad. Sci. U.S.A. 95:1998;5484-5489.
241. Zoroddu M.A., Kowalik-Jankowska T., Kozlowski H., Salnikow K., Costa M. Ni(II) and Cu(II) binding with a 14-aminoacid sequence of Cap43 protein, TRSRSHTSEGTRSR. J. Inorg. Biochem. 84:2001;47-54.
242. Oshiro S., Nozawa K., Hori M., Zhang C., Hashimoto Y., Kitajima S., Kawamura K. Modulation of iron regulatory protein-1 by various metals. Biochem. Biophys. Res. Commun. 290:2002;213-218.
243. Kasprzak K.S., Waalkes M.P., Poirier L.A. Antagonism by essential divalent metals and amino acids of nickel(II)-DNA binding in vitro. Toxicol. Appl. Pharmacol. 82:1986;336-343.
244. Bal W., Kozlowski H., Kasprzak K.S. Molecular models in nickel carcinogenesis. J. Inorg. Biochem. 79:2000;213-218.
245. Bal W., Jezowska-Bojczuk M., Kasprzak K.S. Binding of Ni(II) and Cu(II) to the N-terminal sequence of human protamine HP2. Chem. Res. Toxicol. 10:1997;906-914.
246. 2, a putative metal binding sequence of histone H3. Chem. Res. Toxicol. 8:1995;683-692.
247. Luger K., Mader A.W., Richmond R.K., Sargent D.F., Richmond T.J. Crystal structure of the nucleosome core particle at 2.8 Å resolution. Nature. 389:1997;251-260.
248. 2, a peptide modeling the potential metal binding site in the "C-tail" region of histone H2A. Chem. Res. Toxicol. 11:1998;1014-1023.
249. Zoroddu M.A., Schinocca L., Kowalik-Jankowska T., Kozlowski H., Salnikow K., Costa M. Molecular mechanisms in nickel carcinogenesis: modeling Ni(II) binding site in histone H4. Environ. Health Perspect. 110(Suppl. 5):2002;719-723.
250. Bal W., Karantza V., Moudrianakis E.N., Kasprzak K.S. Interaction of nickel(II) with histones: in vitro binding of Ni(II) to the core histone tetramer. Arch. Biochem. Biophys. 364:1999;161-166.
251. Krezel A., Szczepanik W., Sokolowska M., Jezowska-Bojczuk M., Bal W. Correlations between complexation modes and redox activities of Ni(II)-GSH complexes. Chem. Res. Toxicol. 16:2003;855-864.
252. Bal W., Liang R., Lukszo J., Lee S.H., Dizdaroglu M., Kasprzak K.S. Nickel(II) specifically cleaves the C-terminal tail of the major variant of histone H2A and forms oxidative damage-mediating complex with the cleaved-off octapeptide. Chem. Res. Toxicol. 13:2000;616-624.
253. Ausio J., Abbott D.W. The many tales of a tail: carboxy-terminal tail heterogeneity specializes histone H2A variants for defined chromatin function. Biochemistry. 41:2002;5945-5949.
254. Kasprzak K.S. Possible role of oxidative damage in metal-induced carcinogenesis. Cancer Invest. 13:1995;411-430.
255. Kasprzak K.S. Oxidative DNA and protein damage in metal-induced toxicity and carcinogenesis. Free Radic. Biol. Med. 32:2002;958-967.
256. 2 specifically enhances the formation of oxidants in the nuclei of CHO cells as detected by dichlorofluorescein. Carcinogenesis. 15:1994;545-548.
257. Salnikow K., Gao M., Voitkun V., Huang X., Costa M. Altered oxidative stress responses in nickel resistant mammalian cells. Cancer Res. 54:1994;6407-6412.
258. Herrero M.C., Alvarez C., Cartana J., Blade C., Arola L. Nickel effects on hepatic amino acids. Res. Commun. Chem. Pathol. Pharmacol. 79:1993;243-248.
259. Li W., Zhao Y., Chou I.N. Alterations in cytoskeletal protein sulfhydryls and cellular glutathione in cultured cells exposed to cadmium and nickel ions. Toxicology. 77:1993;65-79.
260. D.W. Margerum, S.L. Anliker, Nickel(III) chemistry and properties of the peptide complexes of Ni(II) and Ni(III), in: J.R. Lancaster (Ed.), The Bioinorganic Chemistry of Nickel, VCH, New York, 1988, pp. 29-51.
261. K.S. Kasprzak, Oxidative DNA damage in metal-induced carcinogenesis, in: L.W. Chang, L. Magos, T. Suzuki, (Eds.), Toxicology of Metals, Lewis Publishers, Boca Raton, 1996, pp. 299-320.
262. J.R. Landolph, Role of free radicals in metal-induced carcinogenesis, in: H. Sigel, A. Sigel (Eds.), Metal Ions in Biological Systems, vol. 36, Marcel Dekker, New York, 1999, pp. 445-483.
263. K.S. Kasprzak, G.S. Buzard, The role of metals in oxidative damage and redox cell signaling derangement, in: J. Koropatnick, R. Zalups (Eds.), Molecular Biology and Toxicology of Metals, Taylor and Francis, London, 2000, pp. 477-527.
264. Costa D., Guignard J., Pezerat H. Production of free radicals arising from the surface activity of minerals and oxygen. Part II. Arsenides, sulfides, and sulfoarsenides of iron, nickel, and copper. Toxicol. Ind. Health. 5:1989;1079-1097.
265. Lee J.E., Ciccarelli R.B., Wetterhahn Jenette K.W. Solubilization of the carcinogen nickel subsulfide and its interaction with deoxyribonucleic acid and protein. Biochemistry. 21:1982;771-778.
266. Tkeshelashvili L.K., Reid T.M., McBride T.J., Loeb L.A. Nickel induces a signature mutation for oxygen free radical damage. Cancer Res. 53:1993;4172-4174.
267. Bal W., Lukszo J., Kasprzak K.S. Mediation of oxidative DNA damage by nickel(II) and copper(II) complexes with the N-terminal sequence of human protamine HP2. Chem. Res. Toxicol. 10:1997;915-921.
268. Bal W., Wojcik J., Maciejczyk M., Grochowski P., Kasprzak K.S. Induction of a secondary structure in the N-terminal pentadecapeptide of human protamine HP2 through Ni(II) coordination. An NMR study. Chem. Res. Toxicol. 13:2000;823-830.
269. Stadtman E.R. Oxidation of free amino acids and amino acid residues in proteins by radiolysis and by metal-catalyzed reactions. Annu. Rev. Biochem. 62:1993;797-821.
270. Requena J.R., Chao C.-C., Levine L.R., Stadtman E.R. Glutamic and aminoadipic semialdehydes are the main carbonyl products of metal-catalyzed oxidation of proteins. Proc. Natl. Acad. Sci. U.S.A. 98:2001;69-74.
271. Stadtman E.R., Berlett B.S. Fenton chemistry: amino acid oxidation. J. Biol. Chem. 266:1991;17201-17211.
272. Zoroddu M.A., Kowalik-Jankowska T., Kozlowski H., Molinari H., Salnikow K., Broday L., Costa M. Interaction of Ni(II) and Cu(II) with a metal binding sequence of histone H4: AKRHRK, a model of the H4 tail. Biochim. Biophys. Acta. 1475:2000;163-168.
273. Berg J.M. Potential metal-binding domains in nucleic acid binding proteins. Science. 232:1986;485-487.
274. S.E. Bryan, Heavy metals in the cell's nucleus, in: G.L. Eichhorn, L.G. Marzili (Eds.), Metal Ions in Genetic Information Transfer, Elsevier, New York, 1981, pp. 87-101.
275. A. Leonard, Chromosome damage in individuals exposed to heavy metals, in: H. Sigel (Ed.), Metal Ions in Biological Systems, vol. 20, Marcel Dekker, New York, 1986, pp. 229-258.
276. Kasprzak K.S., Poirier L.A. Effects of calcium(II) and magnesium(II) on nickel(II) uptake and stimulation of thymidine incorporation into DNA in the lungs of strain A mice. Carcinogenesis. 6:1985;1819-1821.
277. Peskin A.V., Shlyahova L. Cell nuclei generate DNA-nicking superoxide radicals. FEBS Lett. 194:1986;317-321.
278. Dizdaroglu M. Chemical determination of oxidative base damage in DNA by gas chromatography-mass spectrometry. Methods Enzymol. 234:1994;3-16.
279. Nackerdien Z., Kasprzak K.S., Rao G., Halliwell B., Dizdaroglu M. Nickel(II)- and cobalt(II)-dependent damage by hydrogen peroxide to the DNA bases in isolated human chromatin. Cancer Res. 51:1991;5837-5842.
280. Huang X., Kitahara J., Zhitkovich A., Dowjat K., Costa M. Heterochromatic proteins specifically enhance nickel-induced 8-oxo-dG formation. Carcinogenesis. 16:1995;1753-1759.
281. Kasprzak K.S., Bialkowski K. Inhibition of antimutagenic enzymes, 8-oxo-dGTPases, by carcinogenic metals. Recent developments. J. Inorg. Biochem. 79:2000;231-236.
282. Kasprzak K.S., Diwan B.A., Rice J.M., Misra M., Riggs C.W., Olinski R., Dizdaroglu M. Nickel(II)-mediated oxidative DNA base damage in renal and hepatic chromatin of pregnant rats and their fetuses. Possible relevance to carcinogenesis. Chem. Res. Toxicol. 5:1992;809-815.
283. Misra M., Olinski R., Dizdaroglu M., Kasprzak K.S. Enhancement by L-histidine of nickel(II)-induced DNA-protein cross-linking and oxidative DNA base damage in the rat kidney. Chem. Res. Toxicol. 6:1993;33-37.
284. Kasprzak K.S., Jaruga P., Zastawny T.H., North S.L., Riggs C.W., Olinski R., Dizdaroglu M. Oxidative DNA base damage and its repair in kidneys and livers of nickel(II)-treated male F344 rats. Carcinogenesis. 18:1997;271-277.
285. Kawanishi S., Inoue S., Oikawa S., Yamashita N., Toyokuni S., Kawanishi M., Nishino K. Oxidative DNA damage in cultured cells and rat lungs by carcinogenic nickel compounds. Free Radic. Biol. Med. 31:2001;108-116.
286. Kasprzak K.S., Misra M., Rodriguez R.E., North S.L. Nickel-induced oxidation of renal DNA guanine residues in vivo and in vitro. Toxicologist. 11:1991;233.
287. Klein C.B., Frenkel K., Costa M. The role of oxidative processes in metal carcinogenesis. Chem. Res. Toxicol. 4:1991;592-604.
288. Standeven A.M., Wetterhahn K.E. Is there a role for reactive oxygen species in the mechanism of chromium(VI) carcinogenesis? Chem. Res. Toxicol. 4:1991;616-625.
289. Kasprzak K.S., Bare R.M. In vitro polymerization of histones by carcinogenic nickel compounds. Carcinogenesis. 10:1989;621-624.
290. Saplakoglu U., Iscan M., Iscan M. DNA single-strand breakage in rat lung, liver and kidney after single and combined treatments of nickel and cadmium. Mutat. Res. 394:1997;133-140.
291. Cai Y., Zhuang Z. DNA damage in human peripheral blood lymphocyte caused by nickel and cadmium (Chin.). Zhonghua Yu Fang Yi Xue Za Zhi. 33:1999;75-77.
292. Liang R., Senturker S., Shi X., Bal W., Dizdaroglu M., Kasprzak K.S. Effect of Ni(II) and Cu(II) on DNA interaction with the N-terminal sequence of human protamine P2: enhancement of binding and mediation of oxidative DNA strand scission and base damage. Carcinogenesis. 20:1999;893-898.
293. Kawanishi S., Inoue S., Yamamoto K. Site-specific DNA damage by nickel(II) ion in the presence of hydrogen peroxide. Carcinogenesis. 12:1989;2231-2235.
294. Schaaper R.M., Koplitz R.M., Tkeshelashvili L.K., Loeb L.A. Metal-induced lethality and mutagenesis: possible role of apurinic intermediates. Mutat. Res. 177:1987;179-188.
295. Kasprzak K.S., Hernandez L. Enhancement of hydroxylation and deglycosylation of 2′-deoxyguanosine by carcinogenic nickel compounds. Cancer Res. 49:1989;5964-5968.
296. Grollman A.P., Moriya M. Mutagenesis by 8-oxoguanine: an enemy within. Trends Genet. 9:1993;246-249.
297. Hartwig A. Current aspects in metal genotoxicity. BioMetals. 8:1995;3-11.
298. Weitzman S.A. Influence of oxygen radical injury on DNA methylation. Mutat. Res. 386:1997;141-152.
299. Morrison M.K., Kotler J.M., Martin B.D., Sugden K.D. Oxidized guanine lesions as modulators of gene transcription. Biochemistry. 42:2003;9761-9770.
300. Buzard G.S., Kasprzak K.S. Possible roles of nitric oxide and redox cell signaling in metal-induced toxicity and carcinogenesis: a review. J. Environ. Pathol. Toxicol. Oncol. 19:2000;179-199.
301. Bergelson S., Pinkus R., Daniel V. Intracellular glutathione levels regulate fos/jun induction and activation of glutathione S-transferase gene expression. Cancer Res. 54:1994;36-40.
302. 2 and antioxidants have opposite effects on activation of NFkB and AP-1 in intact cells: AP-1 as secondary antioxidant-responsive factor. EMBO J. 12:1993;2005-2015.
303. Costa M., Sutherland J.E., Peng W., Salnikow K., Broday L., Kluz T. Molecular biology of nickel carcinogenesis. Mol. Cell. Biochem. 222:2001;205-211.
304. P. Burtayre, J. Liquier, J. Taboury, L. Pizzorni, J.F. Labarre, E. Taillandier, Z-form induction in DNA by carcinogenic nickel compounds. An optical spectroscopy study, in: F.W. Sunderman Jr., (Ed.), Nickel in the Human Environment, vol. 53, IARC Scientific Publications, Lyon, 1984, pp. 227-234.
305. Rossetto F.E., Nieboer E. The interaction of metal ions with synthetic DNA: induction of conformational and structural transitions. J. Inorg. Biochem. 54:1994;167-186.
306. Sigel H. Metal ions and hydrogen peroxide. XXIX. On the kinetics and mechanism of the catalyse-like activity of nickel(II) and nickel(II) amine complexes. J. Coord. Chem. 3:1974;235-247.
307. Lloyd D.R., Carmichael P.L., Phillips D.H. Comparison of the formation of 8-hydroxy-2′-deoxyguanosine and single- and double-strand breaks in DNA mediated by fenton reactions. Chem. Res. Toxicol. 11:1998;420-427.
308. Sunderman F.W. Jr., Selin C.E. The metabolism of nickel-63 carbonyl. Toxicol. Appl. Pharmacol. 1:1968;297-318.
309. 14C Toxicol. Appl. Pharmacol. 15:1969;295-303.
310. Rokita S.E., Burrows C.J. Nickel- and cobalt-dependent oxidation and crosslinking of proteins. Met. Ions Biol. Syst. 38:2001;289-311.
311. Burrows C.J., Muller J.G. Oxidative nucleobase modifications leading to strand scission. Chem. Rev. 98:1998;1109-1152.
312. Dally H., Hartwig A. Induction and repair inhibition of oxidative DNA damage by nickel(II) and cadmium(II) in mammalian cells. Carcinogenesis. 18:1997;1021-1026.
313. Semenza G.L. Regulation of mammalian O2 homeostasis by hypoxia-inducible factor 1. Annu. Rev. Cell. Dev. Biol. 15:1999;551-578.
314. Horak E., Zygowicz E.R., Tarabishy R., Mitchell J.M., Sunderman F.W. Jr. Effects of nickel chloride and nickel carbonyl upon glucose metabolism in rats. Ann. Clin. Lab. Sci. 8:1978;476-482.
315. Graven K.K., McDonald R.J., Farber H.W. Hypoxia regulation of endothelial glyceraldehyde-3-phosphate dehydrogenase. Am. J. Physiol. 43:1998;347-355.
316. Warburg O. On respiratory impairment in cancer cells. Science. 123:1956;309-314.
317. Chesney J., Mitchell R., Benigni F., Bacher M., Spiegel L., Al-Abed Y., Han J.H., Metz C., Bucala R. An inducible gene product for 6-phosphofructo-2- kinase with an AU-rich instability element: role in tumor cell glycolysis and the Warburg effect. Proc. Natl. Acad. Sci. U.S.A. 96:1999;3047-3052.